Skip to main content
OpenTrials
Completed

NCT Number: NCT04287127

One-stage Bone Lengthening in the Management of Brachymetatarsia

Brachymetatarsia is a shortening in length of a metatarsal exceeding 5mm. This congenital anomaly most often affecting women and the second metatarsal is associated with frequent aesthetic disorders leading patients to consult. The one-time lengthening technique is described for the management of brachymetatarsia with good functional results. However, the metatarsal elongation in one time is limited to 15 millimeters, to avoid complications.

No study has presented the consequences of hypocorrection, especially cosmetic. Our hypothesis is that undercorrection (Hypocorrection) is associated with a higher rate of cosmetic dissatisfaction.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Uhmontpellier

Montpellier, 34295, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients operated on for a one-time lengthening for isolated brachymetatarsia
  • Major patients

Exclusion criteria

  • Patient refusing to participate in research

Treatment and study plan

Primary outcomes

  1. satisfaction using a visual analog scale (from 0/10 to 10/10)

    Time frame: 1 day

    Cosmetic evaluation

Secondary outcomes

  1. radiological evaluation of surgical correction

    Time frame: 1 day

    metatarsal lengtening : mesured on a dorsoplantar radiograph

Sponsors and collaborators

Lead sponsor

University Hospital, Montpellier

Other

Registry information

Official study title

Cosmetic Satisfaction and Undercorrection After One-stage Bone Lengthening in the Management of Brachymetatarsia

Acronym: BRACHYONESTAGE

Important dates

Study start
2019
Primary completion
2019
Study completion
2020
First posted
Feb 27, 2020
Registry last updated
Mar 2, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.